Researchers at the University of Vermont’s Vermont Conversation Lab, including Miller Chair of Palliative Medicine Robert Gramling, M.D., D.Sc., have used machine learning and natural language processing to better understand what conversations surrounding life-threatening and serious illnesses look like, in order to help healthcare providers improve their end-of-life communication. Their work was published December 9 in the journal Patient Education and Counselling.

A new publication by UVM Clinical Instructor in Medicine Daniel Silverman, M.D., and Assistant Professor of Medicine Timothy Plante, M.D., M.H.S., in JAMA Network Open links use of beta-blockers to heart failure hospitalizations among those with this common “stiff heart” heart failure sub-type.

Two University of Vermont Larner College of Medicine faculty have been named to a list of the world’s most influential researchers, based on the number of times their published studies have been cited by other researchers over the past decade. Researchers on the list are in the top 1 percent of all scholars whose work has been cited. The prestigious Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.

The UVM Health Network is partnering with Invitae and LunaPBC on a pilot project to offer Genomic DNA Testing to patients as part of their clinical care. The pilot program is the beginning of an effort to increase the integration of genetic disease risks into routine medical care, which holds promise for providing Vermonters with valuable information to guide their health decisions.